185 related articles for article (PubMed ID: 33912168)
1. Naïve CD4+ T Cell Lymphopenia and Apoptosis in Chronic Hepatitis C Virus Infection Is Driven by the CD31+ Subset and Is Partially Normalized in Direct-Acting Antiviral Treated Persons.
Auma AWN; Shive CL; Lange A; Damjanovska S; Kowal C; Zebrowski E; Pandiyan P; Wilson B; Kalayjian RC; Canaday DH; Anthony DD
Front Immunol; 2021; 12():641230. PubMed ID: 33912168
[TBL] [Abstract][Full Text] [Related]
2. Variable Normalization of Naïve CD4+ Lymphopenia and Markers of Monocyte and T Cell Activation over the Course of Direct-Acting Anti-Viral Treatment of Chronic Hepatitis C Virus Infection.
Auma AWN; Shive CL; Kostadinova L; Anthony DD
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062255
[TBL] [Abstract][Full Text] [Related]
3. Increased peripheral CD4
Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
[TBL] [Abstract][Full Text] [Related]
4. In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment.
Telatin V; Nicoli F; Frasson C; Menegotto N; Barbaro F; Castelli E; Erne E; Palù G; Caputo A
Front Cell Infect Microbiol; 2019; 9():190. PubMed ID: 31259160
[TBL] [Abstract][Full Text] [Related]
5. Reduced naive CD4 T cell numbers and impaired induction of CD27 in response to T cell receptor stimulation reflect a state of immune activation in chronic hepatitis C virus infection.
Yonkers NL; Sieg S; Rodriguez B; Anthony DD
J Infect Dis; 2011 Mar; 203(5):635-45. PubMed ID: 21220773
[TBL] [Abstract][Full Text] [Related]
6. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
Najafi Fard S; Schietroma I; Corano Scheri G; Giustini N; Serafino S; Cavallari EN; Pinacchio C; De Girolamo G; Ceccarelli G; Scagnolari C; Vullo V; d'Ettorre G
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):319-329. PubMed ID: 29279268
[TBL] [Abstract][Full Text] [Related]
7. Immunological recovery in T-cell activation after sustained virologic response among HIV positive and HIV negative chronic Hepatitis C patients.
Emmanuel B; El-Kamary SS; Magder LS; Stafford KA; Charurat ME; Poonia B; Chairez C; McLaughlin M; Hadigan C; Masur H; Kottilil S
Hepatol Int; 2019 May; 13(3):270-276. PubMed ID: 30835046
[TBL] [Abstract][Full Text] [Related]
8. CD4+ T-cell recovery in HIV/hepatitis C co-infected patients following successful hepatitis C treatment.
Ryscavage P; Hussien S; Seung H; Hynicka L
HIV Med; 2024 May; 25(5):622-627. PubMed ID: 38273652
[TBL] [Abstract][Full Text] [Related]
9. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
[TBL] [Abstract][Full Text] [Related]
10. Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals.
Burchill MA; Golden-Mason L; Wind-Rotolo M; Rosen HR
J Viral Hepat; 2015 Dec; 22(12):983-91. PubMed ID: 26482547
[TBL] [Abstract][Full Text] [Related]
11. T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-alfa-2a and ribavirin.
Neau D; Galpérine T; Legrand E; Pitard V; Neau-Cransac M; Moreau JF; Ragnaud JM; Dupon M; Fleury H; Lafon ME
HIV Med; 2003 Apr; 4(2):120-6. PubMed ID: 12702132
[TBL] [Abstract][Full Text] [Related]
12. Influence of hepatitis C virus coinfection on CD4⁺ T cells of HIV-infected patients receiving HAART.
Shmagel KV; Saidakova EV; Korolevskaya LB; Shmagel NG; Chereshnev VA; Anthony DD; Lederman MM
AIDS; 2014 Oct; 28(16):2381-8. PubMed ID: 25111083
[TBL] [Abstract][Full Text] [Related]
13. Successful Direct Acting Antiviral Therapy in Chronic Hepatitis C Normalizes IFNγ and IL2 Production in T Cells Together with TLR8 Expression and Functionality in Peripheral Blood Mononuclear Cells.
Arias-Loste MT; Cabezas J; Llerena S; Iruzubieta P; San-Segundo D; Merino D; Cuadrado A; Vaqué JP; López-Hoyos M; Crespo J
Viruses; 2021 Apr; 13(4):. PubMed ID: 33917265
[TBL] [Abstract][Full Text] [Related]
14. Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers.
Hutchinson JA; Weigand K; Adenugba A; Kronenberg K; Haarer J; Zeman F; Riquelme P; Hornung M; Ahrens N; Schlitt HJ; Geissler EK; Werner JM
Front Immunol; 2018; 9():146. PubMed ID: 29467758
[TBL] [Abstract][Full Text] [Related]
15. Characterizing Hepatitis C Virus-Specific CD4
Hartnell F; Esposito I; Swadling L; Brown A; Phetsouphanh C; de Lara C; Gentile C; Turner B; Dorrell L; Capone S; Folgori A; Barnes E; Klenerman P
Hepatology; 2020 Nov; 72(5):1541-1555. PubMed ID: 32012325
[TBL] [Abstract][Full Text] [Related]
16. Decreased CD4
Wei K; Jiang BC; Guan JH; Zhang DN; Zhang MX; Wu JL; Zhu GZ
Viral Immunol; 2018 Oct; 31(8):559-567. PubMed ID: 30067145
[TBL] [Abstract][Full Text] [Related]
17. T-cell homeostasis in chronic HCV-infected patients treated with interferon and ribavirin or an interferon-free regimen.
Hartling HJ; Birch C; Gaardbo JC; Hove M; Trøseid M; Clausen MR; Gerstoft J; Ullum H; Nielsen SD
APMIS; 2015 Oct; 123(10):903-11. PubMed ID: 26279289
[TBL] [Abstract][Full Text] [Related]
18. Peripheral PD-1
Romani S; Stafford K; Nelson A; Bagchi S; Kottilil S; Poonia B
Front Immunol; 2019; 10():1470. PubMed ID: 31316516
[TBL] [Abstract][Full Text] [Related]
19. T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.
Arizcorreta A; Márquez M; Fernández-Gutiérrez C; Guzmán EP; Brun F; Rodríguez-Iglesias M; Girón-González JA
Clin Exp Immunol; 2006 Nov; 146(2):270-7. PubMed ID: 17034579
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES).
Butt AA; Yan P; Aslam S; Shaikh OS; Abou-Samra AB
Clin Infect Dis; 2020 Mar; 70(6):1153-1160. PubMed ID: 30977808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
